you are currently viewing:Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.February 4, 2026-Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long MRNA ETF (MRNX), expanding its lineup of single-stock leveraged ETFs designed for active traders seeking amplified exposure to innovative companies at the forefront of biotechnology and life sciences. MRNX is designed for traders seeking magnified, short-term bullish exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company known for its messenger RNA (mRNA)-based medicines and vaccine development platform. Source: Defiance ETFs |
December 23, 2025-Both ETFs are first movers in respective stablecoin and tokenization categories
Amplify ETFs, an award winning crypto ETF provider, and leading provider of breakthrough ETF solutions, announces the launch of the first-of-their-kind Amplify Stablecoin Technology ETF (STBQ) and Amplify Tokenization Technology ETF (TKNQ).
December 22, 2025-Sprott Asset Management USA, Inc., a wholly-owned subsidiary of Sprott Inc., today announced methodology changes to the index that Sprott Junior Gold Miners ETF (NYSE Arca: SGDJ) tracks. Junior gold miners, as measured by the Solactive Junior Gold Miners Custom Factors Index, returned more than 171% as of December 19, 2025.